Literature DB >> 11082419

Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis.

A C Hellin1, M Bentires-Alj, M Verlaet, V Benoit, J Gielen, V Bours, M P Merville.   

Abstract

Daunomycin is a potent inducer of p53 and NF-kappaB transcription factors. It is also able to increase the amount of the p21 cyclin-dependent kinase inhibitor. The human p21 promoter harbors p53-responsive elements and an NF-kappaB binding site. We demonstrated, in human breast and colon carcinoma cells, the binding of NF-kappaB dimers to the kappaB site and the transcriptional activation of the human p21 promoter by daunomycin and by NF-kappaB subunits, thereby confirming the functionality of this kappaB binding site. However, using different tumor cell lines where p53 or NF-kappaB was inactive, we showed that p21 activation and cell cycle arrest induced by daunomycin was p53-dependent and NF-kappaB-independent, whereas daunomycin-induced apoptosis was p53- and NF-kappaB-independent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082419

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

Review 1.  Molecular pharmacodynamics in childhood leukemia.

Authors:  R Pieters; M L den Boer
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

2.  Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1.

Authors:  Marianna Penzo; Paul E Massa; Eleonora Olivotto; Francesca Bianchi; Rosa Maria Borzi; Adedayo Hanidu; Xiang Li; Jun Li; Kenneth B Marcu
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 3.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

4.  4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.

Authors:  N J Lee; J H Oh; J O Ban; J H Shim; H P Lee; J K Jung; B W Ahn; D Y Yoon; S B Han; Y W Ham; J T Hong
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

5.  Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid.

Authors:  Rafat A Siddiqui; Laura J Jenski; Kevin A Harvey; Jacqueline D Wiesehan; William Stillwell; Gary P Zaloga
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

6.  Regulation of p53 target gene expression by peptidylarginine deiminase 4.

Authors:  Pingxin Li; Hongjie Yao; Zhiqiang Zhang; Ming Li; Yuan Luo; Paul R Thompson; David S Gilmour; Yanming Wang
Journal:  Mol Cell Biol       Date:  2008-05-27       Impact factor: 4.272

7.  Inhibition of Bacterial Toxin Activity by the Nuclear Stain, DRAQ5™.

Authors:  Joshua N Webb; Evan Koufos; Angela C Brown
Journal:  J Membr Biol       Date:  2016-04-02       Impact factor: 1.843

Review 8.  Many faces of NF-kappaB signaling induced by genotoxic stress.

Authors:  Zhao-Hui Wu; Shigeki Miyamoto
Journal:  J Mol Med (Berl)       Date:  2007-07-03       Impact factor: 4.599

9.  Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.

Authors:  Sarah L Buchan; Aymen Al-Shamkhani
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

10.  Cytoplasmic p21 induced by p65 prevents doxorubicin-induced cell death in pancreatic carcinoma cell line.

Authors:  YingQi Zhou; Gang Li; Yuan Ji; Chen Liu; JingPing Zhu; YanJun Lu
Journal:  J Biomed Sci       Date:  2012-02-04       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.